Streetbeat News

Regulatory

CELU

Celularity has filed an appeal request and an amended compliance plan with Nasdaq. This move is likely in response to a notice of non-compliance with Nasdaq's listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:34 pm

ICU

SeaStar Medical Holding Corporation (NASDAQ:ICU) has announced that Stanford Medicine is cleared to enroll subjects in the NEUTRALIZE-AKI pivotal trial for adult acute kidney injury. This trial now includes 12 sites with 52 subjects enrolled.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:30 pm

CNSP

CNS Pharmaceuticals has requested a hearing with a panel on November 5, 2024, to halt the suspension or delisting of its stock pending a decision.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:16 pm

JSPR

Jasper Therapeutics (NASDAQ:JSPR) is starting an open-label extension study for chronic urticarias, rolling over patients from the BEACON and SPOTLIGHT studies. They have regulatory clearance to expand the BEACON study with a new 360mg dose cohort, with data expected in early 2025.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:15 pm

WINT

Windtree Therapeutics has completed national phase filings of patent applications in the US, Germany, France, Italy, Japan, and China. This move is part of their strategy to protect their intellectual property across key markets.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:13 pm

DBVT

DBV Technologies shares rose following regulatory updates for their Viaskin Peanut patch in the US and Europe.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:10 pm

UPXI

Upexi, Inc. (NASDAQ:UPXI) has regained compliance with Nasdaq's minimum bid price rule after maintaining a closing bid price of $1.00 or greater from October 3 to October 16, 2024. The company plans to file its delayed Form 10-K by November 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:09 pm

BWB

Bridgewater Bancshares, Inc. (NASDAQ:BWB) has received all necessary regulatory approvals to acquire First Minnetonka City Bank. The acquisition is expected to close in Q4 2024, pending customary closing conditions.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:08 pm

ALUR

Allurion Technologies has submitted the first three modules of its Premarket Approval (PMA) application to the FDA for the Allurion Balloon, a weight loss device. This marks a significant step in the regulatory process for the company.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 12:02 pm

GE

GE Aerospace is collaborating with Lilium to develop safety standards for electric vertical takeoff and landing (eVTOL) aircraft. This partnership aims to enhance flight safety in the emerging eVTOL industry.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 11:33 am